Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Broadcom
AVGO
|
+$406M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$351M |
| 3 |
Meta Platforms (Facebook)
META
|
+$316M |
| 4 |
Walmart
WMT
|
+$230M |
| 5 |
ServiceNow
NOW
|
+$217M |
Top Sells
| 1 |
Apple
AAPL
|
+$549M |
| 2 |
Palantir
PLTR
|
+$549M |
| 3 |
Netflix
NFLX
|
+$378M |
| 4 |
NVIDIA
NVDA
|
+$267M |
| 5 |
Alibaba
BABA
|
+$207M |
Sector Composition
| 1 | Technology | 17.41% |
| 2 | Healthcare | 14.96% |
| 3 | Consumer Discretionary | 11.86% |
| 4 | Financials | 11.03% |
| 5 | Industrials | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3026
SES AI
SES
$424M
| $234K | ﹤0.01% |
450,000
-215,300
| -32% | -$112K |
|
3027
TScan Therapeutics
TCRX
$105M
| $234K | ﹤0.01% |
169,706
+159,106
| +1,501% | +$220K |
|
3028
Enliven Therapeutics
ELVN
$1.18B
| $234K | ﹤0.01% |
+11,900
| New | +$234K |
|
3029
iShares ESG Aware MSCI EM ETF
ESGE
$5.34B
| $234K | ﹤0.01% |
6,700
-72,600
| -92% | -$2.54M |
|
3030
First Financial Bankshares
FFIN
$5.13B
| $233K | ﹤0.01% |
+6,500
| New | +$233K |
|
|
IHT
3031
InnSuites Hospitality Trust
IHT
$16.8M
| $233K | ﹤0.01% |
102,903
-1,300
| -1% | -$2.94K |
|
3032
Eletrobras Preferred Shares
EBR.B
$20.4B
| $232K | ﹤0.01% |
29,799
+14,999
| +101% | +$117K |
|
3033
Biodesix
BDSX
$60.6M
| $232K | ﹤0.01% |
370,700
+10,500
| +3% | +$6.57K |
|
3034
FlexShopper
FPAY
$16.9M
| $231K | ﹤0.01% |
180,778
-102,302
| -36% | -$131K |
|
3035
Avalon Holdings
AWX
$9.63M
| $231K | ﹤0.01% |
81,310
+900
| +1% | +$2.56K |
|
3036
Magyar Bancorp
MGYR
$111M
| $231K | ﹤0.01% |
16,586
| – | – |
|
3037
NextCure
NXTC
$14.6M
| $231K | ﹤0.01% |
39,997
-3,278
| -8% | -$18.9K |
|
3038
VirTra
VTSI
$63.4M
| $230K | ﹤0.01% |
56,597
-51,198
| -47% | -$208K |
|
3039
FNB Corp
FNB
$5.9B
| $229K | ﹤0.01% |
17,027
-245,800
| -94% | -$3.31M |
|
3040
Karyopharm Therapeutics
KPTI
$57.6M
| $229K | ﹤0.01% |
61,214
-18,959
| -24% | -$70.9K |
|
3041
Daxor
DXR
$55.4M
| $228K | ﹤0.01% |
28,121
+300
| +1% | +$2.44K |
|
3042
Regis Corp
RGS
$69.1M
| $228K | ﹤0.01% |
12,546
-6,100
| -33% | -$111K |
|
3043
Standard Motor Products
SMP
$901M
| $227K | ﹤0.01% |
+9,100
| New | +$227K |
|
3044
Cytosorbents Corp
CTSO
$59.8M
| $225K | ﹤0.01% |
225,254
+137,234
| +156% | +$137K |
|
3045
Custom Truck One Source
CTOS
$1.33B
| $225K | ﹤0.01% |
+53,200
| New | +$225K |
|
|
MKFG
3046
DELISTED
Markforged Holding Corporation
MKFG
| $224K | ﹤0.01% |
47,939
+4,300
| +10% | +$20.1K |
|
|
LX
3047
LexinFintech Holdings
LX
$988M
| $224K | ﹤0.01% |
22,200
-243,500
| -92% | -$2.46M |
|
3048
Orange County Bancorp
OBT
$356M
| $222K | ﹤0.01% |
9,500
-2,700
| -22% | -$63.2K |
|
|
KG
3049
Kestrel Group, Ltd.
KG
$203M
| $222K | ﹤0.01% |
19,471
-1,175
| -6% | -$13.4K |
|
3050
Inuvo
INUV
$52.3M
| $221K | ﹤0.01% |
62,325
+11,610
| +23% | +$41.2K |
|